首页> 外文期刊>Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy >Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells.
【24h】

Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells.

机译:结缔组织生长因子敲低减弱了在培养的人腹膜间皮细胞中转化生长因子-β1诱导的基质蛋白产生和血管内皮生长因子的表达。

获取原文
获取原文并翻译 | 示例
       

摘要

Connective tissue growth factor (CTGF), a downstream mediator of transforming growth factor-beta1 (TGF-beta1) inducing fibrosis, has recently been implicated in peritoneal fibrosis. Extracellular matrix (ECM) accumulation and angiogenesis are characteristic changes in peritoneal fibrosis. In this study we investigated the effect of CTGF knockdown via interference RNA (RNAi) on ECM production and vascular endothelial growth factor (VEGF) expression induced by TGF-beta1 in human peritoneal mesothelial cells (HPMCs). Four CTGF short hairpin RNA (shRNA) expression constructs were generated using the pRetroSuper vector, and infectious retroviral particles were prepared to infect HPMCs. Expression levels of CTGF, fibronectin(FN), collagen 1 (col 1), laminin, and VEGF mRNA and protein were measured by semi-quantitative reverse transcription polymerase chain reaction and western blot assay. CTGF expression was increased after stimulation with TGF-beta1, but inhibited using each of the four independent CTGF shRNA constructs (P < 0.01). Moreover, expression of ECM proteins (FN, col 1, and laminin) and VEGF were upregulated after incubation with TGF-beta1, but elevated levels of ECM and VEGF induced by TGF-beta1 were significantly inhibited by RNAi (P < 0.01), but not by the empty retroviral vector (P > 0.05). From these results, we concluded that retrovirus-mediated CTGF shRNA can effectively inhibit ECM production and VEGF expression induced by TGF-beta1 in HPMCs. This study suggests that downregulation of CTGF may represent a potential therapeutic approach for peritoneal fibrosis through decreasing ECM accumulation and angiogenesis.
机译:结缔组织生长因子(CTGF)是转化生长因子-β1(TGF-beta1)诱导纤维化的下游介质,最近与腹膜纤维化有关。细胞外基质(ECM)积累和血管生成是腹膜纤维化的特征性变化。在这项研究中,我们研究了通过干扰RNA(RNAi)抑制CTGF对人腹膜间皮细胞(HPMCs)中TGF-beta1诱导的ECM产生和血管内皮生长因子(VEGF)表达的影响。使用pRetroSuper载体生成了四个CTGF短发夹RNA(shRNA)表达构建体,并制备了感染性逆转录病毒颗粒来感染HPMC。通过半定量逆转录聚合酶链反应和蛋白质印迹法检测CTGF,纤连蛋白(FN),胶原蛋白1(col 1),层粘连蛋白和VEGF mRNA和蛋白的表达水平。 TGF-beta1刺激后,CTGF表达增加,但使用四个独立的CTGF shRNA构建体中的每一个均可抑制CTGF表达(P <0.01)。此外,与TGF-β1孵育后,ECM蛋白(FN,col 1和层粘连蛋白)和VEGF的表达上调,但RNAi显着抑制TGF-β1诱导的ECM和VEGF的升高(P <0.01),但而不是空的逆转录病毒载体(P> 0.05)。从这些结果,我们得出结论,逆转录病毒介导的CTGF shRNA可以有效抑制HPMC中TGF-beta1诱导的ECM产生和VEGF表达。这项研究表明,CTGF的下调可能代表通过减少ECM积累和血管生成来治疗腹膜纤维化的潜在治疗方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号